Latest Conference Articles

Lung cancer patients who develop sinus tachycardia due to some treatments for their cancer can successfully reduce their heart rates with ivabradine, researchers in Romania report.

Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.

In the ongoing search for subclinical markers of heart disease, Taiwan researchers found that the diameter of the aortic root is a useful predictor.

Heart failure patients with reduced ejection fraction do better with cardiac interventions, particularly CABG, a meta-analysis of 20 studies found.

Think you should hang up those running shoes after 65? Think again, Finish researchers report. Older people who spent at least 3 hours weekly working up a sweat and high heart rate had fewer heart events.

Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.

Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team's 19 abstracts slated to be presented at the European Society of Cardiology Congress 2016 (ESC).

While Anti-VEGF medications can be an effective treatment for patients with diabetic macular edema many will not respond to it making steroids the preferred method for care.

With medical equipment being universal in operating rooms everywhere having the tools personalized for surgeons could be somewhat of an uphill battle depending on how popular the idea becomes.

While surgeons across the globe have become used to performing procedures with the same equipment as their colleagues there could be some benefit to having tools specifically designed for their individual preferences.

In an age where personalization is a key selling point for many items research is being done as to whether this could apply to equipment eye surgeons use in the operating room.

For patients with retinitis pigmentosa the loss of vision can be a difficult consequence of the condition. An implanted device may not give them back the sight they once had but it can provide a chance to see the world around them in a new way.

Doctors treating patients with age-related macular degeneration face a wide range of complications including the potential dosage for anti-VEGF medications. One question is what role these drugs play in macular atrophy.

As technology improves across the medical spectrum new devices, including implants, are providing help for patients who just a few years ago may not have had any treatment options available.

Researchers set out to see how prevalent sleep problems are in people with age-related macular degeneration (AMD) at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California.

A team from Philadelphia set out to uncover visual outcomes associated with switching to aflibercept from bevacizumab or ranibizumab.

Researchers from three institutions in Illinois collaborated to examine real world visual outcomes for people with wet age-related macular degeneration (AMD) on anti-vascular endothelial growth factor (VEGF) drugs.

In a poster presentation at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California, researchers looked at how patients responded to telemedicine in ophthalmology.

Despite established criteria for patients at risk for vision-threatening diabetic retinopathy from the United Kingdom Prospective Diabetes Study (UKPDS), referral rates don’t reflect the number of people who should visit optometrists, ophthalmologists, and retina specialists.

It’s been unclear whether statins affect the development of diabetic microvascular complications, therefore, Alam Park, MD, from the Ajou University School of Medicine in Korea, and colleagues set out to uncover just that.

Suleyman Kaynak, MD, and colleagues from the Dokuz Eylul University in Turkey, evaluated an alternative therapy for patients who do not respond well to intravitreal ranibizumab.

As new treatments and procedures are developed in the field of retinal medicine the American Society of Retina Specialists is launching its own journal to help its members and others in the field advance patient care.

For those doctors who go through the extended training to be certified retina specialists there is a wealth of knowledge to learn in order to provide the best care for patients.

An analysis presented at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California looked at “real world” outcomes with anti-vascular endothelial growth factor (VEGF) drugs to treat wet age-related macular degeneration (AMD).

Baruch Kuppermann, MD, PhD, and colleagues looked at gene expression modifications in retinal Müller cells treated with anti-VEGFs at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California.

David Eichenbaum, MD, an ophthalmologist from Florida, presented data from the HARBOR study at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California.

Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.

When people think of social networks their immediate reaction may be to think of web based networks and programs. A new recent study looked at the impact of having people to turn to for patients in the early stages of diabetes treatment and beyond.

While it is not yet approved for the treatment of patients with type 1 diabetes recent studies on canagliflozin have shown it could be an option for this patient population.

There are many factors and comorbidities to consider when treating diabetes. Finding the balance of treatment through medications can determine the quality of life of patients as they navigate through the condition.